Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Muscle spasms, Pyrexia, Rash
Clinical narrative: racing pulse of over 110; I could not speak properly; I started to break out in a rash about 1 hour after the shot.  By morning, it covered a large portion of behind my arm, back of legs, and knees.; severe headache; leg and foot cramping; loss of appetite; fever; a foggy feeling where I could not speak properly or keep my thoughts in line.; This is a spontaneous report received from contactable Consumer or other non HCP  (patient). A 49 year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), administered in arm left, administration date 10Sep2021 at 15:30 (Lot number: FC3184) at the age of 49 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Diabetic" (unspecified if ongoing); "Partial Thyroid removal due to noduel." (unspecified if ongoing); "Seafood/Shellfish" (unspecified if ongoing); "Seafood/Shellfish" (unspecified if ongoing); "Pineapple" (unspecified if ongoing). Concomitant medication(s) included: METFORMIN; LOSARTIN; GABAPENTIN; GLIPIZIDE; ZOLOFT. Past drug history included: Known allergies: demerol, reaction(s): "Drug allergy". Vaccination history included: Bnt162b2 (Dose Number:01,Lot number: FC3180, at 03:00 PM in Left arm), administration date: 13Aug2021, when the patient was 49 years old, for Covid-19 Immunization. The patient had not received any other vaccine within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19.  The following information was reported: TACHYCARDIA (medically significant) with onset 10Sep2021 16:30, outcome "not recovered", described as "racing pulse of over 110"; SPEECH DISORDER (non-serious) with onset 10Sep2021 16:30, outcome "not recovered", described as "I could not speak properly"; RASH (non-serious) with onset 10Sep2021 16:30, outcome "not recovered", described as "I started to break out in a rash about 1 hour after the shot.  By morning, it covered a large portion of behind my arm, back of legs, and knees."; HEADACHE (non-serious) with onset 10Sep2021 16:30, outcome "not recovered", described as "severe headache"; MUSCLE SPASMS (non-serious) with onset 10Sep2021 16:30, outcome "not recovered", described as "leg and foot cramping"; DECREASED APPETITE (non-serious) with onset 10Sep2021 16:30, outcome "not recovered", described as "loss of appetite"; PYREXIA (non-serious) with onset 10Sep2021 16:30, outcome "not recovered", described as "fever"; FEELING ABNORMAL (non-serious) with onset 10Sep2021 16:30, outcome "not recovered", described as "a foggy feeling where I could not speak properly or keep my thoughts in line.". The events "racing pulse of over 110", "i could not speak properly", "i started to break out in a rash about 1 hour after the shot.  by morning, it covered a large portion of behind my arm, back of legs, and knees.", "severe headache", "leg and foot cramping", "loss of appetite", "fever" and "a foggy feeling where i could not speak properly or keep my thoughts in line." were evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: heart rate: (10Sep2021) over 110, notes: I also had a racing pulse of over 110. Therapeutic measures were taken as a result of tachycardia, speech disorder, rash, headache, muscle spasms, decreased appetite, pyrexia, feeling abnormal. Since the vaccination, the patient has not been tested for COVID-19.